Home Tags Metastatic Urothelial Cancer

Tag: Metastatic Urothelial Cancer

ESMO 2017 - 3

Interim Phase II Results with Sacituzumab Govitecan in Pretreated Metastatic Urothelial...

Results from an interim Phase II study with sacituzumab govitecan (IMMU-132) shows that the investigational agent is active in patients with metastatic urothelial cancer...

Promising Phase I Data for Enfortumab Vedotin (ASG-22ME) and ASG-15ME in...

The annual congress of the European Society of Medical Oncology (ESMO), this year held in Copenhagen, Denmark (October 7 - 11, 2016) is the premier...

DOWNLOAD